Trastuzumab will be marketed in India under the brand name of CANMAb b...
To fill the existing crucial gap in Research and Development in bulk d...
New shareholders have bought stakes worth a total of €4.5 millio...
In line with the WHO declaration urging individual countries to bolste...
The proposed merger of Abbott Laboratories' Established Pharmaceutical...
This deal will offer Merck increased access to Asian markets. Merck wi...
Pharma Major Lupin's US subsidiary has launched the first product from...
Dr Reddy's Laboratories is set to expand the capacity of three of its ...
The BIG scheme was initiated in order to support entrepreneurs with an...
Aurobindo Pharma eyes globalization and innovation to achieve a turnov...
In response to widespread media reports regarding medical devices, Adv...
The pharmaceutical market in India will continue its double-digit grow...
The Associated Chambers of Commerce and Industry of India (ASSOCHAM) r...
Evolva Holding announces the completion of the acquisition of Allylix,...
Hetero, one of India's leading generic pharmaceutical companies and on...
According to Indian Council of Medical Research (ICMR), there is no ce...
Mr S Raman, VP and head, Biocon Malaysia operations, received the awar...
Dr Cyrus S Poonawalla, chairman and managing director of Serum Institu...
